Therapeutic utility of engineered myeloid cells in the tumor microenvironment
Crossref DOI link: https://doi.org/10.1038/s41417-023-00600-7
Published Online: 2023-02-28
Published Print: 2023-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Canella, Alessandro
Rajappa, Prajwal
Text and Data Mining valid from 2023-02-28
Version of Record valid from 2023-02-28
Article History
Received: 16 November 2022
Revised: 27 January 2023
Accepted: 16 February 2023
First Online: 28 February 2023
Competing interests
: The authors declare no competing interests.